Colgate-Palmolive (CL) – Investment Analysts’ Recent Ratings Changes

A number of research firms have changed their ratings and price targets for Colgate-Palmolive (NYSE: CL):

• 4/11/2025 – Colgate-Palmolive had its price target lowered by analysts at JPMorgan Chase & Co. from $99.00 to $95.00. They now have an “overweight” rating on the stock.
• 4/11/2025 – Colgate-Palmolive had its price target lowered by analysts at Barclays PLC from $89.00 to $86.00. They now have an “equal weight” rating on the stock.
• 4/4/2025 – Colgate-Palmolive was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 4/2/2025 – Colgate-Palmolive had its price target raised by analysts at Wells Fargo & Company from $83.00 to $88.00. They now have an “underweight” rating on the stock.
• 3/31/2025 – Colgate-Palmolive had its price target lowered by analysts at Piper Sandler from $108.00 to $107.00. They now have an “overweight” rating on the stock.
• 3/27/2025 – Colgate-Palmolive had its price target raised by analysts at Barclays PLC from $83.00 to $89.00. They now have an “equal weight” rating on the stock.
• 3/25/2025 – Colgate-Palmolive was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 3/14/2025 – Colgate-Palmolive had its price target raised by analysts at JPMorgan Chase & Co. from $97.00 to $99.00. They now have an “overweight” rating on the stock.
• 3/14/2025 – Colgate-Palmolive was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 3/3/2025 – Colgate-Palmolive was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.

Colgate-Palmolive Price Performance

CL traded up $0.02 on Tuesday, reaching $95.00. The company had a trading volume of 1,206,285 shares, compared to its average volume of 4,565,563. The business has a 50 day simple moving average of $90.65 and a 200 day simple moving average of $92.51. The company has a market cap of $77.05 billion, a price-to-earnings ratio of 26.99, a P/E/G ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the business posted $0.87 EPS. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date is Thursday, April 17th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.50. Colgate-Palmolive’s payout ratio is currently 59.09%.

Hedge Funds Weigh In On Colgate-Palmolive

Hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. raised its holdings in Colgate-Palmolive by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 81,303,059 shares of the company’s stock worth $7,391,261,000 after purchasing an additional 588,230 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Colgate-Palmolive by 1.6% in the 4th quarter. Geode Capital Management LLC now owns 20,518,014 shares of the company’s stock worth $1,868,723,000 after acquiring an additional 324,683 shares in the last quarter. Norges Bank purchased a new position in Colgate-Palmolive during the 4th quarter valued at about $912,375,000. Northern Trust Corp grew its holdings in Colgate-Palmolive by 11.7% in the fourth quarter. Northern Trust Corp now owns 9,497,819 shares of the company’s stock worth $863,447,000 after purchasing an additional 993,328 shares during the period. Finally, Amundi increased its stake in shares of Colgate-Palmolive by 12.8% during the fourth quarter. Amundi now owns 9,200,144 shares of the company’s stock valued at $806,015,000 after purchasing an additional 1,040,604 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.